Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ONY815423
- Development stage
- Preclinical
- Lead developer
- ONY Biotech
01
Overview
ONY815423 is an investigational drug candidate currently in the preclinical stage of development by ONY Biotech. It is being developed for applications within neonatal respiratory medicine (neonatology). As of the current pipeline disclosures, ONY Biotech has not released specific information regarding the drug's molecular target, chemical modality, or precise mechanism of action. The company is well-known for its focus on surfactant replacement therapies, such as its flagship product Infasurf (calfactant), suggesting that ONY815423 may be related to the treatment of Neonatal Respiratory Distress Syndrome (RDS) or other pulmonary conditions affecting newborns.
Beyond the preview
Go deeper on ONY815423.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ONY815423.